3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Hematologic Neoplasms
2
COVID-19
2
Skin Neoplasms
1
Respiratory Sounds
1
Respiratory Distress Syndrome
1
Pneumonia, Viral
1
Pharmacokinetics
1
Neoplasms
1
Lymphoma, Follicular
1
Cytokine Release Syndrome
1
Crohn Disease
1
Bronchiolitis Obliterans Syndrome
1
Asthma
1
Adenomatous Polyposis Coli
1
Interventions
Certolizumab Pegol
5
Infliximab
4
Adalimumab
3
Nivolumab
2
MEDI2070
2
vedolizumab
1
secukinumab
1
golimumab
1
cabozantinib
1
Vitamin E
1
Vaccines
1
Ustekinumab
1
Sutures
1
Surgical Instruments
1
Specimen Handling
1
Soybean Oil
1
Saline Solution
1
Ringer's Lactate
1
Pneumococcal Vaccines
1
Platinum Compounds
1
Photoplethysmography
1
Papillomavirus Vaccines
1
Methoxsalen
1
Medical Marijuana
1
Lysine Acetyltransferase 5
1
Iron-Dextran Complex
1
Ipilimumab
1
Indigo Carmine
1
Hydroxyethyl Starch Derivatives
1
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Crohn Disease
×
Azithromycin
×
Clear all
NCT05599347
2025-04-04
AZITRATIM
Rambam Health Care Campus
Phase 2
Recruiting
180 enrolled